SEROLOGICALS CORP (CIK: 0000767673) EDGAR, Information, Filings... CompaniesBIO.Com

SEROLOGICALS CORP

Mailing address
5655 SPALDING DRIVE, 5655 SPALDING DRIVE, NORCROSS, Delaware, 30092
Phone
4042965595
State location
Georgia
State of incorporation
Delaware
Fiscal year end
December 06
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SEROLOGICALS CORP (CIK: 0000767673) is an American company incorporated in the state of Georgia. Head office is located at 5655 SPALDING DRIVE, 5655 SPALDING DRIVE, NORCROSS, Georgia, 30092. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SEROLOGICALS CORP is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Christoffersen Ralph E	0001316252	Feb-03-2005	director
Ratcliffe Ian W	0001304782	Oct-14-2004	officer: Vice President
Shatkin Aaron J	0001305734	Oct-14-2004	director
Brown Robert J	0001299518	Aug-02-2004	officer: Vice President
Harris Dennis W	0001289902	May-10-2004	officer: Vice President
THEODORE PHILIP A	0001274568	Jan-01-2004	officer: Vice President
VAN DER HOOP ROLAND GERRITSEN	0001193610	Dec-28-2003	officer: Vice President
THOMPSON KEITH J	0001193619	Dec-28-2003	officer: Former VP
BELLITT DAVID L	0001212700	Dec-28-2003	officer: Vice President
CLANIN ROBERT J	0001057426	Jul-24-2003	director
KRAMER JAMES J	0001193613	Jun-03-2003	officer: Vice President
FETZER WADE III	0001060566	May-15-2003	director
MOUFFLET GERARD	0001115048	May-15-2003	director
CHRISTOFFERSEN RALPH E	0001193603	May-15-2003	director
COLLINS ROBERT P	0001193605	May-15-2003	officer: Vice President
DODD DAVID A	0001193607	May-15-2003	director, officer: President and CEO
INGALLS HAROLD W	0001193611	May-15-2003	officer: Vice President & CFO
KOZMA JOSEPH T	0001193612	May-15-2003	officer: Vice President
LINTON JEFFREY D	0001193614	May-15-2003	officer: President Chemicon Division
OCONNELL DESMOND H JR	0001193615	May-15-2003	director
SHAW GEORGE M	0001193617	May-15-2003	director
SUTTON JONES SUE	0001193618	May-15-2003	officer: Vice President
TILTON LAWRENCE E	0001193620	May-15-2003	director
GELBMAN RONALD G	0001210616	May-15-2003	director
SCHWARTZ SAMUEL R	0001218530	May-15-2003	officer: Corporate Controller
WILCOX M DWAIN	0001233512	May-15-2003	officer: Vice President

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SEROLOGICALS CORP

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950134-07-001884 (34 Act) Size: KB	Feb-02-2007	005-46047 07576941
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001102578-06-000192 (34 Act) Size: KB	Aug-10-2006	005-46047 061019589
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000908733-06-000038 (34 Act) Size: KB	Aug-07-2006	005-46047 061008528
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-043038 ( Act) Size: 0 KB	Jul-28-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-043035 ( Act) Size: 0 KB	Jul-28-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-043033 ( Act) Size: 0 KB	Jul-28-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-043031 ( Act) Size: 0 KB	Jul-28-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-043028 ( Act) Size: 0 KB	Jul-28-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042561 ( Act) Size: 0 KB	Jul-27-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042560 ( Act) Size: 0 KB	Jul-27-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042559 ( Act) Size: 0 KB	Jul-27-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042229 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042215 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042214 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042213 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042212 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042211 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042210 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042208 ( Act) Size: 0 KB	Jul-25-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-06-042206 ( Act) Size: 0 KB	Jul-25-2006

Recent 20 filings. View all SEROLOGICALS CORP filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

SEROLOGICALS CORP overview
SEROLOGICALS CORP job
SEROLOGICALS CORP stock
SEROLOGICALS CORP ownership
SEROLOGICALS CORP CEO
SEROLOGICALS CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.